Gonçalo Rebelo de Andrade is Chief of Business Operations at Nanoform Finland. Before that he was Director at Hovione Technology. He holds a PhD in Biochemistry from Ludwig Maximillian University in Munich and earned his Lisbon MBA course degree at Nova/Catolica Business School. He joined the Hovione group in 2013 as a business development manager for inhalation drug development services and for the dry powder inhalers within Hovione’s portfolio, which he led until March 2016. Dr Andrade has >15 years’ experience in the life sciences sector in the US, Germany and Portugal where he worked for both large companies and startups and a clear vision on the hurdles connected to the drug development of inhaled drugs.
Eunice Costa, Filipe Neves, Gonçalo Andrade and Conrad Winters describe the strong position of inhalable products in preclinical and clinical pipelines and make the case for formulation-based approaches to enable and enhance pulmonary product development. Spray-drying technology in particular is highlighted as a highly favourable, scalable manufacturing technique for inhalable composite particles.